Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15480257 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 | |
| SCHEMBL7695792 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 | |
| SCHEMBL29862279 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 | |
| SCHEMBL30003607 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 | |
| SCHEMBL7649857 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 | |
| SCHEMBL9719263 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 | |
| SCHEMBL145456 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 | |
| SCHEMBL31565013 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 | |
| SCHEMBL148189 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 | |
| SCHEMBL9777327 | 1.00 | MEN1 (0.46) | MEN1KMT2APOLBALDH1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3719056-B1 | ORGANIC GROUP-MODIFIED ORGANOSILICON RESIN, PRODUCTION METHOD THEREOF, AND COSMETIC | SHINETSU CHEMICAL CO (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-20240182736-A1 | INK SET, INKJET RECORDING METHOD, INK MEDIUM SET, AND PRINTING MEDIUM | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-4316849-A1 | INK SET, INKJET RECORDING METHOD, INK MEDIUM SET, AND PRINTING MEDIUM | Nippon Kayaku Kabushiki Kaisha (JP) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022203041-A1 | INK SET, INKJET RECORDING METHOD, INK MEDIUM SET, AND PRINTING MEDIUM | 日本化薬株式会社 | 2022-09-29 | — | — | WO | disclosed |
| US-7553819-B2 | Multivalent inhibitors of serum amyloid P component | THERACARB INC. (CA) | 2009-06-30 | — | — | US | disclosed |
| US-20070042936-A1 | Multivalent inhibitors of serum amyloid p component | THERACARB INC. | 2007-02-22 | — | — | US | disclosed |
| US-5162402-A | For concrete containing a polymeric composition | SANDOZ LTD. (CH) | 1992-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042936-A1 | Multivalent inhibitors of serum amyloid p component | IAPP, APP, PRNP | MEN1 3324/4885KMT2A 3940/4885POLB 3526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.